Dimpy Mehra, PharmD

Bristol Myers Squibb

Poster(s):

• P0756 - Durability of Symptomatic and Clinical Outcomes in Ozanimod-Treated Patients by Endpoints of Increasing Objectivity at True North Week 52: Interim Analysis of the True North Open-Label Extension Study
  Sunday, October 22, 2023

  3:30 PM – 7:00 PM PT